Advanced CKD was linked to a higher likelihood of both fatal and non-fatal adverse outcomes after acute myocardial infarction treatment. Patients with advanced chronic kidney disease (ACKD) with acute ...

No association seen for incontinence with MVPA classification, but link seen with type 2 diabetes, dyslipidemia, stroke.

AstraZeneca has made the decision to end the CAPItello-280 trial evaluating capivasertib in patients with metastatic castration-resistant prostate cancer.

Addition of revascularization to optimized medical therapy not beneficial in patients with carotid stenosis ≥50 percent and low or intermediate predicted stroke risk.

Now, as the new commissioner of the U.S. Food and Drug Administration (FDA), he's wasting no time charting a new course for the agency.

Some benefits include mitigation of cardiac toxicity, peripheral neuropathy, cognitive impairment, and dyspnea. (HealthDay News) — Exercise mitigates adverse outcomes associated with cancer and ...

The combination of toripalimab, nimotuzumab, and chemotherapy has shown promise as neoadjuvant treatment for patients with high-risk, locally advanced penile cancer, according to researchers.

An estimated 40 to 63 percent of sudden cardiac arrest cases could be prevented by improving unfavorable profiles. (HealthDay News) — Modifiable, nonclinical risk factors such as lifestyle ...

Maternal HDP linked to worse BSID cognitive and language scores in preterm infants later on. (HealthDay News) — Maternal hypertensive disorders of pregnancy (HDP) are associated with adverse ...

Radiation from CT scans may cause as many as 5% of cancers diagnosed each year in the United States, research suggests.

Rectifying understaffing reduces length of stay, readmissions, and deaths. (HealthDay News) — Addressing nursing understaffing improves outcomes for hospitalized patients, according to a study ...

Lorundrostat treatment led to greater reductions in 24-hour mean blood pressure compared with placebo in trial participants with uncontrolled and treatment-resistant hypertension. Lorundrostat, a ...